Archive · 21 Aug 2025
Drug Labs Report Substandard and Spurious Medicines
Government labs regularly check medicines to ensure they are good quality.
In July 2025, they found that some medicines didn't meet the required standards, which means they might not work as intended.
They also found some fake medicines.
These medicines were made by unauthorized manufacturers using brand names owned by other companies.
Officials say the failure is specific to the drug products of the batch tested and they are taking action to remove these substandard and spurious drugs.
Central Drugs Laboratories identified 46 drug samples as 'not of standard quality'.
State drug testing laboratories identified 97 drug samples as NSQ.
Seven spurious drug samples originated from Bihar.
One spurious drug sample originated from CDSCO North Zone, Ghaziabad.
Officials said the failure is specific to the drug products of the batch tested by the government laboratory.
- Who
- Central Drugs Laboratories, State drug testing laboratories, and health ministry officials.
- What
- Central and State drug labs found numerous drug samples of 'not of standard quality' and some spurious drugs.
- When
- July 2025, with ongoing regulatory surveillance.
- Where
- India, with samples identified across various states.
- Why
- To ensure drug quality and remove substandard and spurious drugs from the market.
Health Ministry
Drug Manufacturers
Drug Quality
Health Ministry
Prioritizes public health and safety through rigorous drug quality control.
Drug Manufacturers
N/A
- NSQ Samples (Central Lab)
- 46
- NSQ Samples (State Labs)
- 97
- Spurious Samples (Bihar)
- 7
- Spurious Samples (Ghaziabad)
- 1
